Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P0
Near historical low
vs 3Y Ago
-284.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -267.14% |
| Q3 2025 | 269.71% |
| Q2 2025 | 47.07% |
| Q1 2025 | 14.93% |
| Q4 2024 | -55.99% |
| Q3 2024 | 50.36% |
| Q2 2024 | 9.53% |
| Q1 2024 | -86.60% |
| Q4 2023 | 5.87% |
| Q3 2023 | -12.76% |
| Q2 2023 | 10.42% |
| Q1 2023 | -43.67% |
| Q4 2022 | 0.94% |
| Q3 2022 | -2.98% |
| Q2 2022 | -14.92% |
| Q1 2022 | -3.88% |
| Q4 2021 | -5.48% |
| Q3 2021 | 2.83% |
| Q2 2021 | -7.95% |
| Q1 2021 | 20.96% |
| Q4 2020 | -14.83% |
| Q3 2020 | -97.25% |
| Q2 2020 | 20.48% |
| Q1 2020 | -148.38% |
| Q4 2019 | -8.46% |
| Q3 2019 | 1.87% |
| Q2 2019 | -78.14% |
| Q1 2019 | -3.40% |
| Q4 2018 | -19.61% |
| Q3 2018 | 2.28% |
| Q2 2018 | 37.99% |
| Q1 2018 | -45.40% |
| Q4 2017 | -20.08% |
| Q3 2017 | 35.28% |
| Q2 2017 | -102.86% |
| Q1 2017 | 28.58% |
| Q4 2016 | -175.90% |
| Q3 2016 | 198.39% |
| Q2 2016 | 42.12% |
| Q1 2016 | 36.84% |